Helen Goodridge, PhD
Professor
Cedars-Sinai Medical Center
Alba Grifoni, PhD
La Jolla Institute for Immunology
David Nemazee, Ph.D.
Scripps Research
Carey Killion, BS, MT(ASCP), CHS(ACHI)
KSL Diagnostics
With multiple approaches to assess HLA eplets and molecular mismatches, there is intense interest in improving the sensitivity and biological relevance of these models by identifying those most likely to stimulate an alloimmune response. This is widely being called “immunogenicity,” but the definitions and biology of antigenic vs. immunogenic properties need to be considered as we move forward. This session will cover features of antigens that make them more or less able to be recognized by T/B cells, then discuss the role of antigen presenting cells and their activation state as determinants of adaptive immune activation. Lastly, we will translate these premises to the biology of B cells and alloantibody production.
Session developed by Carey Killion and Nicole Valenzuela, program planning committee.
Speaker: Alba Grifoni, PhD – La Jolla Institute for Immunology
Speaker: Helen Goodridge, PhD – Cedars-Sinai Medical Center
Speaker: David Nemazee, Ph.D. – Scripps Research